Lenvatinib (lenvatinib) latest market price and purchasing advice in 2025

As of2025, Lenvatinib (also known as Lenvatinib, Lenvatinib) has been officially launched in China and has been successfully included in the national medical insurance directory, greatly reducing the financial burden on patients. Lenvatinib is a multi-target tyrosine kinase inhibitor that is widely used to treat a variety of solid tumors such as advanced thyroid cancer, hepatocellular carcinoma, and renal cancer. The common domestic specifications are 4 mg × 30 tablets, and the price per box is about 3,000 yuan. Patients can buy it at the pharmacy of a top-grade hospital or a qualified pharmacy with a prescription.

With the support of domestic medical insurance, the actual price paid for lenvatinib can be further reduced. The specific amount after medical insurance reimbursement varies depending on the region and reimbursement policies. In some areas, the monthly out-of-pocket amount of patients can even be controlled within a thousand yuan. It is recommended that patients confirm the reimbursement ratio and deductible with the attending doctor and the medical insurance department before taking medication, so as to reasonably arrange treatment and financial expenses.

For patients who cannot afford the price of the original drug or are not covered by medical insurance reimbursement, they may also consider purchasing the overseas version of lenvatinib. Currently, the original drug of lenvatinib is sold in European, American and Asian markets, and some countries such as India, Bangladesh and Laos have also launched generic versions. The price of overseas original drugs is about 2000 yuan, while the price of generic drugs in Laos and Bangladesh is more affordable, usually between 400 and 900 yuan. The ingredients of the drug are consistent with the original drug and the efficacy is similar, making it a more cost-effective alternative.

Taken together, 2025 Lenvatinib has a stable supply in both domestic and foreign markets, with a clear price gradient and a large choice space. If domestic patients meet the conditions for medical insurance, it is recommended that they give priority to using medical insurance to purchase drugs in regular hospitals to ensure medication safety and continuity of treatment. If you consider purchasing drugs overseas, you should obtain them through qualified cross-border medical platforms or channels to avoid purchasing counterfeit or substandard drugs. Reasonable drug selection under the guidance of a doctor is the key to improving treatment effects and ensuring drug safety.

Reference materials:https://www.drugs.com/